Phenotypic Diversity of Cardiomyopathy Caused by an

Joonhong Park, Jong-Min Lee, Jung Sun Cho

Open access · goldAbstract readCase Reports

In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.3field-weighted citation impact, top 41% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy.International journal of molecular sciences · 2023
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Joonhong ParkDepartment of Laboratory Medicine, Jeonbuk National University Medical School and Hospital, Jeonju 54907, Korea.ORCID 0000-0001-7354-4234

Jong-Min LeeDepartment of Cardiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

Jung Sun ChoDepartment of Cardiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0002-0308-0021

Catholic University of Korea · KRJeonbuk National University Hospital · KR

Funding

National Research Foundation of Korea 2020R1F1A1077316

6 · The paper itself

Abstract

Restrictive cardiomyopathy (RCM) is one of the rarest cardiac disorders, with a very poor prognosis, and heart transplantation is the only long-term treatment of choice. We reported that a Korean family presented different cardiomyopathies, such as idiopathic RCM and hypertrophic cardiomyopathy (HCM), caused by the same

Indexed as

Cardiomyopathy, Hypertrophic, FamilialFrameshift MutationAgedCarrier ProteinsHumansMaleMutationPedigreePhenotypeRepublic of KoreaCarrier Proteinscardiac magnetic resonance imagehypertrophic cardiomyopathyMYBPC3 mutationphenotypic diversityrestrictive cardiomyopathywhole exome sequencing

Identifiers

PMID33803538

DOI10.3390/medicina57030281

PMCPMC8002862

OpenAlexW3139255179

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.